Literature DB >> 11956115

Noninvasive imaging of myocardial reperfusion injury using leukocyte-targeted contrast echocardiography.

Jonathan P Christiansen1, Howard Leong-Poi, Alexander L Klibanov, Sanjiv Kaul, Jonathan R Lindner.   

Abstract

BACKGROUND: We hypothesized that myocardial contrast echocardiography (MCE) with leukocyte-targeted microbubbles could temporally and spatially characterize the severity of postischemic myocardial inflammation. METHODS AND
RESULTS: In 9 open-chest dogs, either the left anterior descending or left circumflex coronary artery was occluded for 90 minutes (n=6), while the remaining dogs served as non-ischemic controls. During occlusion, MCE was performed to determine the risk area (RA) and regions supplied by collateral flow. Myocardial inflammation was assessed 5, 60, and 120 minutes after reflow by MCE imaging of leukocyte-targeted (phosphatidylserine-containing) lipid microbubbles. The spatial extent and severity of inflammation were also assessed by radionuclide imaging of the neutrophil-avid tracer 99mTcRP517 and tissue myeloperoxidase activity. Early after reflow, MCE detected inflammation throughout the entire risk area, the extent of which decreased over time due to reduced signal in collateral-supplied regions. The spatial extent of inflammation late after reflow was similar for MCE and radionuclide imaging. The severity of inflammation in the infarct zone, the noninfarcted risk area, and collateral-supplied territories determined by quantitative MCE correlated well with myeloperoxidase activity (r=0.81).
CONCLUSIONS: MCE with leukocyte-targeted microbubbles can temporally assess the severity and extent of postischemic myocardial inflammation and could be used to evaluate new treatment strategies designed to limit inflammation in acute coronary syndromes.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11956115     DOI: 10.1161/01.cir.0000015466.89771.e2

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  40 in total

Review 1.  Imaging myocardial metabolic remodeling.

Authors:  Robert J Gropler; Rob S B Beanlands; Vasken Dilsizian; E Douglas Lewandowski; Flordeliza S Villanueva; Maria Cecilia Ziadi
Journal:  J Nucl Med       Date:  2010-05-01       Impact factor: 10.057

Review 2.  Molecular imaging with contrast ultrasound and targeted microbubbles.

Authors:  Jonathan R Lindner
Journal:  J Nucl Cardiol       Date:  2004 Mar-Apr       Impact factor: 5.952

3.  Molecular ultrasound imaging and its potential for paediatric radiology.

Authors:  Isabel Kiessling; Jessica Bzyl; Fabian Kiessling
Journal:  Pediatr Radiol       Date:  2010-08-03

Review 4.  Molecular imaging with contrast enhanced ultrasound.

Authors:  Scott M Chadderdon; Sanjiv Kaul
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

Review 5.  The role of cardiac ultrasound in stem cell therapy.

Authors:  Andrew M Kahn; Anthony N Demaria
Journal:  J Cardiovasc Transl Res       Date:  2009-01-22       Impact factor: 4.132

Review 6.  "Eat me" imaging and therapy.

Authors:  Vaishali Bagalkot; Jeffrey A Deiuliis; Sanjay Rajagopalan; Andrei Maiseyeu
Journal:  Adv Drug Deliv Rev       Date:  2016-01-27       Impact factor: 15.470

Review 7.  Cardiac imaging in the evaluation of patients presenting to the emergency department with chest pain.

Authors:  Jared J Wyrick; Kevin Wei
Journal:  J Nucl Cardiol       Date:  2006-11       Impact factor: 5.952

8.  Asymmetric oscillation of adherent targeted ultrasound contrast agents.

Authors:  Shukui Zhao; Katherine W Ferrara; Paul A Dayton
Journal:  Appl Phys Lett       Date:  2005-09-26       Impact factor: 3.791

Review 9.  Microbubbles and ultrasound: a bird's eye view.

Authors:  Sanjiv Kaul
Journal:  Trans Am Clin Climatol Assoc       Date:  2004

Review 10.  Targeted delivery of therapeutics to endothelium.

Authors:  Eric Simone; Bi-Sen Ding; Vladimir Muzykantov
Journal:  Cell Tissue Res       Date:  2008-09-25       Impact factor: 5.249

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.